Maf1 cooperates with progesterone receptor to repress RNA polymerase III transcription of select tRNAs
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf1176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Jessica Finlay-Schultz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States. Hauptthemen laut MEDLINE: RNA Polymerase III, Receptors, Progesterone, RNA, Transfer, Transcription, Genetic. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Breast Cancer Research Foundation, NIDDK NIH HHS, American Cancer Society.
Abstract (Originalsprache)
Progesterone receptors (PRs) can regulate transcription by RNA polymerase III (Pol III), which transcribes small non-coding RNAs, including all transfer RNAs (tRNAs). We previously demonstrated that PR is associated with the Pol III complex at tRNA genes and that progestins downregulate tRNA transcripts in breast tumor models. To define this mechanism, we investigated the interplay between PR, the Pol III repressor Maf1, and TFIIIB, a core transcription component. ChIP-seq was performed for PR, the Pol III subunits POLR3A, POLR3C, and POLR3G, the TFIIIB component Brf1, and Maf1 in breast cancer cells with or without progestin treatment. With progestin treatment, PR localized to ∼50% of POLR3A-occupied tRNA genes, with Maf1 co-recruited at many of these sites. Progestin treatment did not significantly alter the number of tRNA genes occupied by Pol III subunits or Brf1; however, Brf1 occupancy was stabilized. Progestins downregulated nascent transcription of one-third of tRNA genes; this repression was attenuated by Maf1 knockdown, indicating that Maf1 is required. The PR and Maf1 interaction was also detected by co-immunoprecipitation in a progestin-dependent manner. Overall, these findings demonstrate a ligand-dependent PR-mediated repression of tRNA transcription that involves Maf1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
- Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
- RNA Bioscience Initiative, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
- Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, United States.
ORCID-Profile: Jessica Finlay-Schultz, Kiran Vinod Paul, Benjamin Erickson, Deborah L Johnson, David L Bentley, Peter Kabos, Carol A Sartorius
Förderung
- Breast Cancer Research Foundation
- NIDDK NIH HHS
- American Cancer Society
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Finlay-Schultz, J., Vinod Paul, K., Erickson, B., Fettig, L. M., Hastings, B. S., Johnson, D. L., Bentley, D. L., Kabos, P., & Sartorius, C. A. (2025). Maf1 cooperates with progesterone receptor to repress RNA polymerase III transcription of select tRNAs. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf1176
Vancouver
Finlay-Schultz J, Vinod Paul K, Erickson B, Fettig LM, Hastings BS, Johnson DL, et al. Maf1 cooperates with progesterone receptor to repress RNA polymerase III transcription of select tRNAs. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf1176
BibTeX
@article{FinlaySchultz2025,
author = {Finlay-Schultz, Jessica and Vinod Paul, Kiran and Erickson, Benjamin and Fettig, Lynsey M and Hastings, Benjamin S and Johnson, Deborah L and Bentley, David L and Kabos, Peter and Sartorius, Carol A},
title = {Maf1 cooperates with progesterone receptor to repress RNA polymerase III transcription of select tRNAs},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf1176}
}
EUVIMED